ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AMGN Amgen Inc

269.98
0.60 (0.22%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Amgen Inc NASDAQ:AMGN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.60 0.22% 269.98 268.90 273.24 271.68 265.72 265.72 2,436,961 01:00:00

ADRs End Mixed; Sanofi Trades Actively

05/10/2017 10:41pm

Dow Jones News


Amgen (NASDAQ:AMGN)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Amgen Charts.
   By Austen Hufford 
 

International stocks trading in New York closed mixed on Thursday.

The BNY Mellon index of American depositary receipts was largely flat at 149.25. The European index was little changed at 139.17. The Asian index firmed 0.2% to 172.07. The emerging-markets index declined 0.2% to 259.15. The Latin American index slipped 0.2% to 259.15.

Spanish banks were among those with ADRs that traded actively.

 

Spanish bank stocks recovered somewhat after a top court in the country suspended Catalonia's planned parliamentary session on independence. They fell Wednesday amid growing political tension between Madrid and Barcelona over the independence referendum. ADRs of Banco Santander SA (SAN, SAN.MC) advanced 2.3% to $6.70 and Banco Bilbao Vizcaya Argentaria SA (BBVA, BBVA.MC) rose 2.1% to $8.51.

 

ADRs of Sanofi SA (SNY) climbed 1.2% to $50.61 as a U.S. federal appeals court said that it and Regeneron Pharmaceuticals Inc. can continue selling their cholesterol drug, dealing a blow to rival Amgen Inc., which had accused the companies of violating its patents.

 

ADRs of EDAP TMS SA (EDAP) continued to rise Thursday after the U.S. Food and Drug Administration approved its Ablatherm-Fusion device, allowing for a more precise method of targeting diagnosed areas. ADRs rose more than 11% to $3.39.

 

ADRs of GOL Linhas Aereas Inteligentes SA (GOL) rose 4.7% to $23.90 after the company released preliminary results for its latest quarter. Passenger unit revenue for the third quarter is expected to rise 6% to 6.5%.

 

Write to Austen Hufford at austen.hufford@wsj.com

 

(END) Dow Jones Newswires

October 05, 2017 17:26 ET (21:26 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Amgen Chart

1 Year Amgen Chart

1 Month Amgen Chart

1 Month Amgen Chart

Your Recent History

Delayed Upgrade Clock